换一批
换一批Systematic review and meta-analysis of the effect of iron chelation therapy on overall survival and disease progression in patients with lower-risk myelodysplastic syndromes.
第一作者：
Amer M,Zeidan
第一单位：
Yale University School of Medicine and Yale Cancer Center, Smilow Cancer Hospital at Yale New Haven, New Haven, CT, USA. amer.zeidan@yale.edu.
作者：
主题词
临床试验(主题)(Clinical Trials as Topic);无病生存(Disease-Free Survival);女(雌)性(Female);人类(Humans);铁螯合剂(Iron Chelating Agents);男(雄)性(Male);模型, 生物学(Models, Biological);骨髓增生异常综合征(Myelodysplastic Syndromes);危险因素(Risk Factors);存活率(Survival Rate)
DOI
10.1007/s00277-018-3539-7
PMID
30413901
发布时间
2019-01-28
- 浏览41
Annals of hematology
339-350页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
